Frustrated Patients Want Doctors, Not Apps, to Cut Their Drug Costs

AUSTIN, Texas – March 10, 2026 – An overwhelming majority of insured Americans are sending a clear message to the healthcare industry: they want their doctors, not a new app or website, to take charge of lowering their prescription drug costs. A new national survey reveals that nearly 84% of insured patients want their providers to automatically select lower-cost, clinically appropriate medications on their behalf, signaling a deep-seated frustration with the current system's complexity and opacity.

The findings, part of the 2026 State of Drug Access Survey released today by pharmacy technology firm RazorMetrics, paint a picture of a patient population burdened by both high prices and the growing challenge of managing multiple medications. Based on responses from 1,000 insured U.S. adults, the report suggests that the prevailing model of shifting cost-navigation responsibility onto patients is failing to meet their needs and is actively eroding trust.

The Silent Burden of Medication Overload

For a significant and growing portion of the population, managing prescriptions has become a confusing and stressful part-time job. The survey found that nearly two-thirds of patients taking five or more medications—a condition known as polypharmacy—describe the experience as confusing, laden with side effects, and difficult to manage. This aligns with broader public health data, which shows the prevalence of polypharmacy has more than doubled among U.S. adults over the past two decades, affecting over 44% of older Americans.

"Polypharmacy is experienced as a daily cognitive load, not just a clinical condition," said Tom Dorsett, CEO of RazorMetrics, in a statement accompanying the release. "It is not surprising that patients prefer their own physician to automatically review and reduce their prescription burden... Patients are already managing enough. Adding cost navigation with new digital tools to an already complex regimen only increases friction and frustration."

The consequences of this burden are tangible. The survey highlights that when faced with high costs, 16% of patients resort to leaving prescriptions unfilled or rationing their medication—actions that can lead to poor health outcomes and increased long-term healthcare spending. This cognitive and financial strain directly undermines medication adherence, a cornerstone of managing chronic disease.

A Crisis of Trust in Prescription Pricing

Beyond the complexity of managing multiple pill bottles, the survey exposes a profound lack of faith in the pricing of medications. More than half (56%) of insured patients do not trust that they are paying the lowest available price for their prescriptions. That mistrust is even more concentrated among those who find the system confusing, with 68% of that group reporting they do not trust pricing outcomes.

This sentiment is hardly surprising. For years, patients have found themselves at the mercy of a notoriously opaque supply chain dominated by pharmacy benefit managers (PBMs), whose rebate negotiations and complex formularies often obscure the true cost of drugs. The issue has drawn the attention of regulators, culminating in recent legislative actions like the Consolidated Appropriations Act of 2026, which aims to force greater transparency and delink PBM compensation from drug prices in Medicare.

While these systemic reforms slowly take shape, patients are left grappling with the immediate impact. The RazorMetrics survey found that 43% of respondents were prescribed a drug in the last year that was simply too expensive. Furthermore, the report notes that sticker shock is a common experience even for everyday medications, with nearly four in five patients experiencing affordability stress for costs well below the $250 mark.

In response to this, a market of patient-facing discount apps and platforms has emerged. However, the survey suggests these are not the solution patients are looking for. Nearly half of respondents described such tools as hard to navigate, overwhelming, or inconsistent, reinforcing the desire for a less fragmented and more integrated approach to affordability.

Patients Demand a Physician-Led Solution

The central message from the survey is a call to shift the responsibility for cost optimization away from the patient and back into the clinical setting. Patients are not asking for more tools to do their own research; they are asking for a system that works for them proactively.

"Medicine always has been, and always will be, patient-first. Our national study makes clear that patients want their own physician to automatically select lower-cost, clinically equivalent options for them," said Siva Mohan, MD, president and chief medical officer at RazorMetrics. "They want costs and risks addressed earlier, automatically, and clinically by their personal physician, working for them in the background before they ever know there's a problem."

This desire for a trusted, automated solution managed by a healthcare professional stands in stark contrast to the current reality for many. The complexity of insurance formularies, prior authorizations, and rebate systems often leaves physicians themselves in the dark about the final cost a patient will face at the pharmacy counter. This disconnect between the prescribing decision and its financial consequences is a key source of the friction and distrust identified in the survey.

"Programs that rely on patient initiation are destined, by design, to underperform," Mohan continued. "Predictable pricing, proactive optimization, and physician decision-making consistently outperform reactive, patient-driven models."

The Rise of Automated, In-Workflow Optimization

Meeting this patient demand requires a fundamental rewiring of how prescription decisions are made. Technology companies like RazorMetrics are pioneering this shift by embedding cost-saving intelligence directly into physicians' existing electronic health record (EHR) workflows. This model identifies lower-cost, clinically appropriate alternatives—such as a different drug in the same class or a therapeutic equivalent—and presents them to the provider at the point of care.

The key distinction is that the intervention is automated, clinical, and provider-approved. Changes are made with the physician's consent before the prescription is even sent, sparing the patient the downstream confusion of pharmacy phone calls, insurance denials, or unexpected bills. By operating inside the clinical workflow, these platforms can analyze a specific health plan's formulary in real-time to find the most effective and affordable option.

This approach represents a significant evolution from the patient-facing discount cards or the opaque administrative processes of traditional PBMs. It aligns with a broader trend in health IT toward real-time analytics and seamless integration to improve decision-making and reduce administrative waste. By arming physicians with actionable pricing and formulary information when it matters most, this new generation of technology aims to absorb the system's complexity. The goal is to deliver a pharmacy experience that is simpler, more affordable, and ultimately more aligned with what patients repeatedly say they want.